Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-07-22
1991-08-27
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, A61K 3743, C07K 710
Patent
active
050433229
ABSTRACT:
Synthetic peptides which stimulate the release of pituitary GH in animals, including humans, and are more resistant to enzymatic degradation in the body than hGRF having the sequence: (B)R.sub.1 -R.sub.2 R.sub.3 -Ala-Ile-Phe-Thr-R.sub.8 -Ser-R.sub.10 -Arg-R.sub.12 R.sub.13 -Leu-R.sub.15 -Gln-Leu-R.sub.18 -Ala-Arg-R.sub.21 -R.sub.22 -Leu-R.sub.24 -R.sub.25 -Ile-R.sub.27 -R.sub.28 -R.sub.29 -Gln-Gln-Gly-Glu-R.sub.34 -Asn-Gln-Glu-R.sub.38 R.sub.39 -R.sub.40 -Arg-R.sub.42 -R.sub.43 -R.sub.44 wherein R.sub.1 is Tyr, D-Tyr, Met, D-Met, Phe, D-Phe, pCl-Phe, Leu, His or D-His; B is H, C.sup.a Me, N.sup.1 Me, desamino, Ac or For; R.sub.2 is Ala, D-Ala, NMA or D-NMA; R.sub.3 is Asp or D-Asp; R.sub.8 is Ser, Asn, Lys, Arg, Asp or Gln; R.sub.10 is Tyr, D-Tyr or Phe; R.sub.12 is Arg or Lys; R.sub.13 is Ile, Val, Leu or Ala; R.sub.15 is Gly, Ala or .beta.-Ala; R.sub.18 is Ser or Tyr; R.sub.21 is Lys, D-Lys, Arg or D-Arg; R.sub.22 is Leu, Ile, Ala or Val; R.sub.24 is Gln or His; R.sub.25 is cys, abu, asp, glu, orn, lys, dab or dap; R.sub.27 is Met, D-Met, Ala, Nle, Ile, Leu, Nva or Val; R.sub.28 is Asn or Ser; R.sub.29 is cys, abu, asp, glu, orn, lys, dab or dap; R.sub.34 is Ser or Arg; R.sub.38 is Arg or Gln; R.sub.39 is Gly or Arg; R.sub.40 is Ala or Ser; R.sub.42 is Phe or Ala; R.sub.43 is Asn or Arg; R.sub.44 is a natural amino acid, such as Leu or Val. C-terminal sequences of from 1 to 15 residues beginning at R.sub.44 and extending as far as up to R.sub.29 may be deleted. These peptides as well as their nontoxic salts may also be used diagnostically.
REFERENCES:
patent: 4518586 (1985-05-01), Rivier et al.
patent: 4528190 (1985-07-01), Vale, Jr. et al.
patent: 4563352 (1986-01-01), Rivier et al.
patent: 4595676 (1986-06-01), Spiess et al.
patent: 4626523 (1986-12-01), Vale, Jr. et al.
patent: 4661472 (1987-04-01), Rivier et al.
patent: 4689318 (1987-08-01), Kaiser et al.
patent: 4734399 (1988-03-01), Felix et al.
patent: 4784987 (1988-11-01), Rivier et al.
Felix et al., "Synthesis and Biological Activity of Novel Linear and Cyclic GRF Analogs," Peptides 1987, pp. 465-467, Ed. by Garland R. Marshall, ESCOM, Leiden, 1988.
Rivier Catherine L.
Rivier Jean E. F.
Vale, Jr. Wylie W.
Lee Lester L.
Marshall S. G.
The Salk Institute for Biological Studies
LandOfFree
Cyclic GRF analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic GRF analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic GRF analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1414212